Skip to main content

Table 1 Baseline patient characteristics for 1,571 patients by age groups

From: Traumatic brain injury—the effects of patient age on treatment intensity and mortality

 

15-24yrs

25-34yrs

35-44yrs

45-54yrs

55-64yrs

65-74yrs

75-84yrs

 ≥ 85yrs

Count (n, %)

179 (100)

168 (100)

153 (100)

197 (100)

258 (100)

297 (100)

197 (100)

122 (100)

Male sex (n, %)

134 (74.9)

134 (79.8)

125 (81.7)

145 (73.6)

195 (75.6)

201 (67.7)

112 (56.9)

46 (37.7)

Pre-injury ASA-score (n, %)

 1

165 (92.2)

134 (79.8)

102 (66.7)

114 (57.9)

72 (27.9)

66 (22.2)

18 (9.1)

4 (3.3)

 2

11 (6.1)

26 (15.5)

31 (20.3)

45 (22.8)

88 (34.1)

127 (42.8)

86 (43.7)

30 (24.6)

 3

3 (1.7)

7 (4.2)

20 (13.1)

38 (19.3)

97 (37.6)

97 (32.7)

91 (46.2)

85 (69.7)

 4

0 (0)

1 (0.6)

0 (0)

0 (0)

1 (0.4)

7 (2.4)

2 (1.0)

3 (2.5)

Pre-injury living (n, %)

 Independent

176 (98.3)

162 (96.4)

147 (96.1)

185 (93.9)

236 (91.5)

269 (90.6)

155 (78.7)

51 (41.8)

 Home with assistance

1 (0.6)

5 (3.0)

4 (2.6)

8 (4.1)

20 (7.8)

22 (7.4)

29 (14.7)

54 (44.3)

 Institutionalised

2 (1.1)

1 (0.6)

2 (1.3)

4 (2.0)

2 (0.8)

6 (2.0)

13 (6.6)

17 (13.9)

Pre-injury antithrombotics (n, %)

 Anticoagulation

1 (0.6)

0 (0)

5 (3.3)

2 (1.0)

14 (5.4)

33 (11.1)

52 (26.4)

38 (31.1)

 Platelet inhibitor

0 (0)

0 (0)

1 (0.7)

10 (5.1)

38 (14.7)

87 (29.3)

68 (34.5)

45 (36.9)

 Platelet inhibitor + anticoagulation

0 (0)

0 (0)

1 (0.7)

1 (0.5)

3 (1.2)

7 (2.4)

7 (3.6)

2 (1.6)

GCS (mean)

10.0

11.0

11.1

11.0

11.2

11.8

11.4

12.5

HISS (n, %)

 Mild

62 (34.6)

83 (49.4)

68 (44.4)

81 (41.1)

111 (43.0)

134 (45.1)

94 (47.7)

73 (59.8)

 Moderate

50 (27.9)

32 (19.0)

41 (26.8)

58 (29.4)

74 (28.7)

100 (33.7)

50 (25.4)

32 (26.2)

 Severe

67 (37.4)

53 (31.5)

44 (28.8)

58 (29.4)

73 (28.3)

63 (21.2)

53 (26.9)

17 (13.9)

Pathoanatomy (n, %)

 Skull fracture

121 (67.6)

107 (63.7)

95 (62.1)

125 (63.5)

135 (52.3)

133 (44.8)

56 (28.4)

36 (29.5)

 SDH

72 (40.2)

73 (43.5)

65 (42.5)

109 (55.3)

169 (65.5)

192 (64.6)

133 (67.5)

77 (63.1)

 tSAH

80 (44.7)

104 (61.9)

93 (60.8)

116 (58.9)

170 (65.9)

189 (63.6)

118 (59.9)

72 (59.0)

 EDH

47 (26.3)

35 (20.8)

34 (22.2)

36 (18.3)

33 (12.8)

28 (9.4)

9 (4.6)

5 (4.1)

 Brain contusion

100 (55.8)

82 (48.8)

82 (53.6)

102 (51.8)

138 (53.5)

137 (46.1)

87 (44.2)

48 (39.3)

Rotterdam CT score (n, %)

 1,2

103 (57.5)

82 (48.8)

60 (39.2)

76 (38.6)

83 (32.2)

89 (30.0)

44 (22.3)

38 (31.1)

 3,4

66 (36.9)

67 (39.9)

80 (52.3)

101 (51.3)

152 (58.9)

182 (61.3)

132 (67.0)

73 (59.8)

 5,6

10 (5.6)

19 (11.3)

13 (8.5)

20 (10.2)

23 (8.9)

26 (8.8)

21 (10.7)

11 (9.0)

Multiple trauma (n, %)

 Yes

101 (56.4)

94 (56.0)

78 (51.0)

122 (61.9)

134 (51.9)

127 (42.8)

76 (38.6)

40 (32.8)

 No

78 (43.6)

74 (44.0)

75 (49.0)

75 (38.1)

124 (48.1)

170 (57.2)

121 (61.4)

82 (67.2)

Management intensity (n, %)

 TTA

165 (92.2)

140 (83.3)

129 (84.3)

167 (84.8)

214 (82.9)

205 (69.0)

127 (64.5)

69 (56.6)

 CTA/CTV/MRA/MRV

112 (62.6)

97 (57.7)

84 (54.9)

123 (62.4)

164 (63.6)

163 (54.9)

84 (42.6)

21 (17.2)

 MR

90 (50.3)

52 (31.0)

52 (34.0)

69 (35.0)

75 (29.1)

50 (16.8)

21 (10.7)

4 (3.3)

 Ventilator therapy

97 (54.2)

69 (41.1)

65 (42.5)

89 (45.2)

119 (46.1)

112 (37.7)

69 (35.0)

22 (18.0)

 ICP-monitor

62 (34.6)

40 (23.8)

42 (27.5)

59 (29.9)

81 (31.4)

59 (19.9)

27 (13.7)

3 (2.5)

 Evacuation of mass lesion

18 (10.1)

22 (13.1)

27 (17.6)

27 (13.7)

43 (16.7)

49 (16.5)

20 (10.2)

10 (8.2)

 Decompressive craniectomy

4 (2.2)

4 (2.4)

6 (3.9)

9 (4.6)

4 (1.6)

4 (1.3)

0 (0)

0 (0)

  1. ASA American Society of Anesthesiologists, LOC Loss of consciousness, GCS Glasgow Coma Scale, HISS Head Injury Severity Scale, SDH Subdural haematoma, tSAH Traumatic subarachnoidal haemorrhage, EDH Epidural haematoma, TTA Trauma team activation, CTA Computed tomography angiography, CTV Computed tomography venography, MRA Magnetic resonance angiography, MRV Magnetic resonance venography, MR Magnetic resonance, ICP Intracranial pressure monitor